News
Pfizer Stock: Nearing 52-Week Lows Amid Challenges
Pfizer's stock currently faces a challenging market position, trading precariously close to its 52-week lows. The shares recently showed minimal recovery, rising just 0.2 percent to $25.99 in New
Merit Medical Stock: Executives Sell Shares Amid Strong Performance
In early March 2025, Merit Medical Systems' leadership team executed significant stock transactions totaling over $7 million. CEO Fred Lampropoulos sold 34,319 shares at prices between $103.75 and
Chimerix Stock: Shares Soar 69% in Pre-Market
Chimerix, a biotechnology company, experienced a remarkable surge in its stock price during Wednesday's pre-market trading, with shares climbing over 69% to reach $8.41. This exceptional performance
Cerus Stock: Execs Sell Shares Amid Strong Financials
Cerus Corp (NASDAQ: CERS) recently saw several top executives sell company shares as part of a pre-established trading plan in early March 2025. CEO William Greenman sold 23,023 shares at an average
Pfizer Stock: Court Ruling Clouds Positive Momentum
Pfizer shares gained 0.9 percent on Wednesday in New York trading, closing at $25.98 after reaching an intraday high of $26.17. Investor interest remained strong with over one million shares
Pfizer Stock: Court Ruling Clouds Positive Momentum
Pfizer shares gained 0.9 percent on Wednesday in New York trading, closing at $25.98 after reaching an intraday high of $26.17. Investor interest remained strong with over one million shares
Abbott Laboratories Stock: Executives Sell Shares Near 52-Week High
Abbott Laboratories is experiencing notable stock market activity as multiple senior executives recently divested portions of their holdings. Former Executive Vice President Andrea F. Wainer sold
Handelsupdate für das Gesamtjahr
Ad hoc Ankündigung gemäß Art. 53 LR
Pratteln, Schweiz, 4. März 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt heute ein Handelsupdate für das Geschäftsjahr 2024 und einen Ausblick für 2025 und
EQS-News: Evotec gibt wichtige Fortschritte in der Neurologie-Partnerschaft mit Bristol Myers Squibb bekannt
Merit Medical Stock: Executives Sell Shares Amid Strong Performance
Merit Medical Systems Inc., a medical technology company with a market capitalization of $6.08 billion, has experienced significant stock transactions by its leadership team. The company's chief
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius kündigt hiermit die Absicht an, ihren Anteil an der Fresenius Medical Care AG von derzeit rund 32,2 % auf nicht weniger als 25 % plus eine Aktie zu reduzieren
Vertex Stock: Executives Sell Shares Amid Strong Performance
Vertex Pharmaceuticals Inc. has seen significant insider selling activity recently, with top executives divesting substantial shareholdings while the company's stock enjoys impressive performance
Vertex Stock: Executives Sell Shares Amid Strong Performance
Vertex Pharmaceuticals Inc. has seen significant insider selling activity recently, with top executives divesting substantial shareholdings while the company's stock enjoys impressive performance
Vertex Stock: Executives Sell Shares Amid Strong Performance
Vertex Pharmaceuticals Inc. has seen significant insider selling activity recently, with top executives divesting substantial shareholdings while the company's stock enjoys impressive performance
OraSure Stock: Insiders Bet Big Near 52-Week Low
OraSure Technologies' stock is experiencing significant insider buying activity as multiple executives made substantial investments while shares trade near their 52-week low of €2.69. CEO Carrie
Novavax Stock: Narrowing Losses Drive Market Confidence
Novavax has significantly reduced its net loss in the fourth quarter of 2024 to $81.03 million ($0.51 per share), a substantial improvement from the $178.39 million ($1.44 per share) loss reported
EQS-News: Eckert & Ziegler und Bicycle Therapeutics schließen strategische Partnerschaft zur Lieferung von Radioisotopen sowie zur Entwicklung und Produktion von Bicycle Radio Conjugates
EQS-News: Eckert & Ziegler und Bicycle Therapeutics schließen strategische Partnerschaft zur Lieferung von Radioisotopen sowie zur Entwicklung und Produktion von Bicycle Radio Conjugates
Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has gone relatively unnoticed from major headlines in 2024 as GLP-1 makers like Novo Nordisk A/S
Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has gone relatively unnoticed from major headlines in 2024 as GLP-1 makers like Novo Nordisk A/S
Regeneron: Is It the Perfect Biotech Stock for Value and Growth?
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) stock has gone relatively unnoticed from major headlines in 2024 as GLP-1 makers like Novo Nordisk A/S
Exelixis Stock: Executives Sell as Shares Near Peak
Exelixis is experiencing significant insider selling activity while its stock trades near its 52-week high of €37.64. Three high-ranking executives recently reduced their holdings in substantial
Ocular Therapeutix Stock: Executive Sales Amidst Clinical Progress
Ocular Therapeutix, Inc. (NASDAQ: OCUL), the biotechnology firm with a market capitalization of $1.06 billion, recently reported several stock transactions by its leadership team. CEO Pravin Dugel
Eli Lilly and Stock: Massive $27B US Manufacturing Investment
Pharmaceutical giant Eli Lilly and Company, now the world's most valuable pharma corporation with a market capitalization exceeding $855 billion, announced Wednesday it will invest an additional $27
Vertex erweitert die Kapazitäten für e-Invoicing zur Optimierung von Compliance & Reporting
KING OF PRUSSIA, Pa., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Vertex Inc. (NASDAQ:VERX) („Vertex“ oder das „Unternehmen“) ein globaler Anbieter von Steuertechnologie-Lösungen, präsentiert die neueste